BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| BAL27862 | BAL27862 is a novel synthetic potent inhibitor of tubulin polymerization that induces cancer cell death. BAL27862 is a novel microtubule-destabilizing drug that is currently undergoing phase I clinical evaluation as the prodrug BAL101553. Synonyms: Avanbulin; BAL-27862; BAL 27862. Grades: 98%. CAS No. 798577-91-0. Molecular formula: C20H17N7O2. Mole weight: 387.40. |  |
| Bamlanivimab | Bamlanivimab is a monoclonal antibody granted Emergency Use Authorization (EUA) in November 2020 by FDA for COVID-19 therapy. Bamlanivimab is directed against the spike protein of SARS-CoV-2, designed to block the virus' attachment and entry into human cells. Synonyms: Anti-Human SARS-CoV-2; LY-CoV555; LY3819253. CAS No. 2423943-37-5. | |
| Banoxantrone | Banoxantrone is a bioreductive, alkylaminoanthraquinone prodrug with antineoplastic activity. Under hypoxic conditions, often seen in solid tumors, banoxantrone (AQ4N) is converted and activated by cytochrome P450 enzymes, which are upregulated in certain tumors, to the cytotoxic DNA-binding agent AQ4. Banoxantrone intercalates into and crosslinks DNA, and inhibits topoisomerase II. Synonyms: AQ-4N; AZD-1689; AQ4N; AZD1689; AQ 4N; AZD 1689. CAS No. 136470-65-0. Molecular formula: C22H28N4O6. Mole weight: 444.48. | |
| Bapineuzumab | Bapineuzumab is a humanized monoclonal antibody that targets the N-terminal region of A&beta. Bapineuzumab has been investigated in Alzheimer's disease therapy. CAS No. 648895-38-9. | |
| Batoclimab | Batoclimab is a humanized monoclonal antibody targeting the neonatal Fc receptor (FcRn). Batoclimab binds to and inhibits FcRn, thus blocking the recycling of IgG antibodies. Batoclimab can be used in the research of pathogenic IgG-mediated autoimmune diseases. Synonyms: HBM9161; IMVT-1401. CAS No. 2187430-05-1. | |
| Bay 11-7085 | BAY 11-7085 is an irreversible inhibitor of TNFα-induced IκBα phosphorylation with IC50 of 10 μM. Synonyms: Bay 11-7085; Bay-11-7085; Bay11-7085; Bay 117085; Bay-117085; Bay117085. Grades: >98%. CAS No. 196309-76-9. Molecular formula: C13H15NO2S. Mole weight: 249.33. | |
| BAY-1895344 hydrochloride | BAY-1895344 is a potent, orally available and highly selective ATR inhibitor (IC50= 7 nM), which potently inhibits proliferation of a broad spectrum of human tumor cell lines (median IC50 = 78 nM). In cellular mechanistic assays BAY 1895344 potently inhibited hydroxyurea-induced H2AX phosphorylation (IC50 = 36 nM). Synonyms: Elimusertib hydrochloride; BAY 1895344 hydrochloride; BAY1895344 hydrochloride; 2-[(3R)-3-Methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridine hydrochloride; 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine hydrochloride; Bay 1895344; 1,7-Naphthyridine, 2-[(3R)-3-methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-, hydrochloride (1:1). Grades: ≥95%. Molecular formula: C20H22ClN7O. Mole weight: 411.89. | |
| BAY 2416964 | BAY 2416964 is a potent, orally active, aromatic hydrocarbon receptor (AHR) antagonist, which has the potential to treat solid tumors. Synonyms: BAY2416964; (S)-6-(4-Chlorophenyl)-N-(1-Hydroxypropan-2-Yl)-2-(1-Methyl-1H-Pyrazol-4-Yl)-3-Oxo-2,3-Dihydropyridazine-4-Carboxamide. Grades: ≥98% by HPLC. CAS No. 2242464-44-2. Molecular formula: C18H18ClN5O3. Mole weight: 387.8. | |
| BAY-386 | BAY-386 is a novel PAR1 receptor inhibitor that suppresses activation of thrombin and platelet. It is orally active, and has the potential to treat coagulation disorders such as arterial thrombosis. Uses: The potential treatment of coagulation disorders. Synonyms: BAY 386; BAY386. CAS No. 1256941-06-6. Molecular formula: C22H25F3N4O5S. Mole weight: 514.52. | |
| BAY 56-3722 | BAY 56-3722 is a water-soluble camptothecin derivative conjugated to a carbohydrate moiety exhibiting antineoplastic activity. BAY 56-3722 stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex. The peptide carbohydrate moiety of this agent stabilizes the lactone form of camptothecin in blood. Synonyms: BAY-563722; BAY56 3722; BAY 38-3441; BAY 38 344; (S)-4-ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl ((4-(((2R,3S,4R,5R,6S)-3,5-dihydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)phenyl)carbamothioyl)-L-histidyl-L-valinate. CAS No. 215604-75-4. Molecular formula: C45H50ClN7O11S. Mole weight: 895.98. | |
| BAY 56-3722 hydrochloride | BAY 56-3722, a water-soluble camptothecin derivative, is a DNA-Intercalating drug that stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex. Synonyms: BAY 56-3722; BAY56-3722; BAY-56-3722; N-[4- (6-Deoxy-3-O-methyl-beta-L-galactopyranosyloxy) phenylaminothiocarbonyl]-L-histidyl-L-valine 4(S)-ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl ester hydrochloride; N-[4-(3-O-Methyl-beta-L-fucopyranosyloxy)p; Afeletecan hydrochloride; BAY 38-3441; L-Valine, N- ( ( (4- ( (6-deoxy-3-O-methyl-beta-L-galactopyranosyl) oxy) phenyl) amino) thioxomethyl) -L-histidyl-, (4S)-4-ethyl-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-4-yl ester, hydrochloride (1:1); 215604-75-4 (BAY 56-3722 free base); 215604-74-3 (BAY 56-3722 HCl salt; 215604-66-3 (diastereomeric mixture). Grades: >98%. CAS No. 215604-74-3. Molecular formula: C45H49N7O11S.HCl. Mole weight: 932.447. | |
| BAY-671 | BAY-671 is developed from the structure of BRD4 inhibitor used for the treatment of solid tumor. Studies in vtro and in vivo indicated that it has inhibitory effect on multiple cancer types. Uses: The treatment of solid tumor. Synonyms: BAY 671; BAY671. | |
| Bayer9017 | Bayer9017 is a bio-active chemical compound. Synonyms: Bayer 9017; Bayer-9017; 3,5-Xylenol, 4-(methylthio)-, O-ester with O,O-diethyl phosphorothioate; Phosphorothioic acid, O-(3,5-dimethyl-4-(methylthio)phenyl) O,O-diethyl ester; BAY 9017. Grades: 98%. CAS No. 52-60-8. Molecular formula: C13H21O3PS2. Mole weight: 320.43. | |
| Bazedoxifene HCl | Cas No. 198480-56-7. | |
| BBS 4 | BBS4, inhibits the dimerization of iNOS monomers, is a potent, orally active and selective inducible nitric oxide synthase dimerization inhibitor. Uses: Inos dimmerization inbibitor. Synonyms: BBS4; BBS-4; (R)-1-(2-(1H-imidazol-1-yl)-6-methylpyrimidin-4-yl)-N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)pyrrolidine-2-carboxamide. Grades: ≥98%. CAS No. 402934-09-2. Molecular formula: C22H24N6O3. Mole weight: 420.47. | |
| b-Cellobiosyl azide | b-Cellobiosyl azide is a highly versatile biomedical compound, acting as a precursor for synthesizing glycoconjugates and glycosylated natural drugs. Leveraging its profound influence on protein function and stability, this remarkable compound has become extensively utilized in cutting-edge drug development and advanced pharmaceutical investigations. Synonyms: 4-O-b-D-Glucopyranosyl-b-D-glucopyranosyl azide. CAS No. 69194-62-3. Molecular formula: C12H21N3O10. Mole weight: 367.3. | |
| BCG Vaccine | BCG Vaccine is a vaccine primarily used against tuberculosis (TB). BCG also has some effectiveness against Buruli ulcer infection and other nontuberculous mycobacterial infections. Additionally, it is sometimes used as part of the treatment of bladder cancer. Synonyms: Bacillus Calmette. | |
| b-Chloralose | b-Chloralose is a renowned compound employed for the research of sedation and anesthesia functioning as a central nervous system depressant. Uses: Anesthetics, intravenous. Synonyms: beta-Chloralose; 16376-36-6; 7CUN2U7N0Q; DTXSID4046575; (1R)-1-[(2S,3aR,5R,6S,6aR)-6-hydroxy-2-(trichloromethyl)-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol; alpha-D-Glucofuranose, 1,2-O-[(1S)-2,2,2-trichloroethylidene]-; (R)-1-((2S,3aR,5R,6S,6aR)-6-hydroxy-2-(trichloromethyl)tetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethane-1,2-diol; |A-Chloralose; UNII-7CUN2U7N0Q; NSC-52806; NCGC00166244-01; EINECS 240-429-2.BETA.-CHLORALOSE; SCHEMBL9714720; DTXCID2026575; OJYGBLRPYBAHRT-GVUNPQSCSA-N; (S)-1,2-O-(2,2,2-Trichloroethylidene)-alpha-D-glucofuranose; Tox21_112370; NSC 52806; AKOS015913708; CAS-16376-36-6; CS-0447761; W-204208; Q27268085; A-D-GLUCOFURANOSE,1,2-O-[(1S)-2,2,2-TRICHLOROETHYLIDENE]-.ALPHA.-D-GLUCOFURANOSE, 1,2-O-((1S)-2,2,2-TRICHLOROETHYLIDENE)-CHLORALOSE. BETA.-. CAS No. 16376-36-6. Molecular formula: C8H11Cl3O6. Mole weight: 309.53. | |
| b-Core-APE-HSA | | |
| b-D-Allopyranose | b-D-Allopyranose, an essential monosaccharide, finds extensive utility within the biomedicine sector. Its status as a natural product adds to its credibility. Primarily regarded as a precursor, this compound plays a crucial role in synthesizing diverse drugs and compounds. These substances, in turn, cater to combating diabetes, cancer, and viral infections. Remarkably, the distinctiveness of b-D-Allopyranose's structure is attributed to its extraordinary therapeutic benefits. By enhancing glucose metabolism, restraining tumor growth, and countering viral replication, researchers and pharmaceutical enterprises find immense value in this compound. Synonyms: beta-D-allose; beta-D-allopyranose; 7283-09-2; (2R,3R,4R,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; B-D-ALLOPYRANOSE; JJ05IRR0HO; MFCD00063268; b-d-allose; 1rpj; beta -D-Allose; beta-D,L-Allose.beta.-D-Allose; ?-D-Allose; D(+)- Allose; D-Allose, 98%; UNII-JJ05IRR0HO.BETA.-D-ALLOPYRANOSE; SCHEMBL624762; CHEBI:40656; WQZGKKKJIJFFOK-QZABAPFNSA-N; DTXSID301015883; beta-D-Allopyranose, beta-D-Allose; AKOS024437744; FS-5229; CS-0142451; F73485; beta-D-allose; D-allose; allose; D-ALLOPYRANOSE; W-200609; Q27104464; 9E6E796A-1C95-45F3-8B7A-D05D3DEBE575; (2R,3R,4R,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol. CAS No. 7283-9-2. Molecular formula: C6H12O6. Mole weight: 180.16. | |
| b-D-Arabinofuranose | b-D-Arabinofuranose is an invaluable compound acting as a fundamental component in the research of nucleosides and nucleotides alike. It forges an indomitable pathway towards pioneering breakthroughs in the expansive domain of antiviral pharmaceutical developments. CAS No. 25545-03-3. | |
| b-D-Galactoheptose | b-D-Galactoheptose is a remarkable biomedical substance, renowned for its exceptional efficacy in studying a wide array of inflammatory disorders and autoimmune afflictions. This alluring compound, sourced from nature's bounties, deftly modulates intricate immune mechanisms. Synonyms: D-Glycero-L-gluco-heptose. CAS No. 23102-92-3. Molecular formula: C7H14O7. Mole weight: 210.18. | |
| b-D-Galactopyranosyl amine | b-D-Galactopyranosyl amine, a pivotal compound highly sought after in the biomedical field due to its multifaceted utility, finds itself at the forefront of cutting-edge research and innovation. Serving as a foundational unit in the intricate assemblage of diverse pharmaceutical formulations, it assumes a pronounced role in the combat against ailments such as cancer, diabetes, and cardiovascular maladies. Synonyms: 1-Amino-1-deoxy-b-D-galactose. CAS No. 74867-91-7. Molecular formula: C6H13NO5. Mole weight: 179.17. | |
| b-D-Galactosylceramide | | |
| b-D-Glucopyranoside,4-(hydroxymethyl)phenyl, 2,3,4,6-tetraacetate | b-D-Glucopyranoside,4-(hydroxymethyl)phenyl, 2,3,4,6-tetraacetate is a derivative of b-D-Glucopyranoside,4-(hydroxymethyl)phenyl, exhibiting significant versatility in multifarious biomedical endeavors encompassing drug developmental investigations and scientific explorations. Synonyms: Acegastrodine. Grades: >98%. CAS No. 64291-41-4. Molecular formula: C21H26O11. Mole weight: 454.42. | |
| b-D-Glucopyranosyl amine | b-D-Glucopyranosyl amine is an eminent biomedical compound, showcasing its profound prowess in studying the formidable diabetes. Synonyms: 1-Deoxy-1-amino-β-D-glucose; 1-Amino-1-deoxy-b-D-glucose; Glucopyranosylamine; (2R,3R,4S,5S,6R)-2-Amino-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. Grades: ≥95%. CAS No. 7284-37-9. Molecular formula: C6H13NO5. Mole weight: 179.17. | |
| b-D-Glucopyranosyl nitromethane | b-D-Glucopyranosyl nitromethane, a compound extensively utilized in the biomedical sector, displays immense worth. Operating as a transitional compound, it aids in the production of glycosylated medicines, including antiviral and anti-inflammatory agents. Further, it assumes a momentous function in addressing specific ailments such as diabetes and cancer. The remarkable qualities of b-D-Glucopyranosyl nitromethane render it an indispensable element in biomedical exploration and advancement of pharmaceuticals. Synonyms: beta-D-glucopyranosyl nitromethane; 81846-60-8; b-D-Glucopyranosyl nitromethane; (2R,3S,4R,5R,6S)-2-(HYDROXYMETHYL)-6-(NITROMETHYL)OXANE-3,4,5-TRIOL; beta-D-Glucopyranosylnitromethane; SCHEMBL6135980; DTXSID60628688; CNILFIXWGGSLAQ-PJEQPVAWSA-N; AKOS040758367; BS-24308; HY-141490; CS-0173381; E87966; 2,6-Anhydro-1-deoxy-1-nitro-D-glycero-D-gulo-heptitol; (2R,3S,4R,5R,6S)-2-(Hydroxymethyl)-6-(nitromethyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 81846-60-8. Molecular formula: C7H13NO7. Mole weight: 223.18. | |
| b-D-Thiogalactose | b-D-Thiogalactose is an essential biomedical compound, exhibiting remarkable potential in research of galactosemia, a multifaceted metabolic anomaly predicated on the inability to metabolize galactose. Functioning as an efficacious inhibitor, this compound deftly curtails galactose levels within the corporeal domain, skillfully impeding its pernicious aggregation. Molecular formula: C6H12O5S. Mole weight: 196.22. | |
| b-D-Thiogalactose sodium salt | b-D-Thiogalactose sodium salt, a chemical compound utilized in biomedical research to scrutinize specific enzymatic reactions of sugars and carbohydrates, is also a significant component in the synthesis of chemical probes which could deepen our comprehension of selected biological processes. Its prospective therapeutic applications not only pertain to tackling metabolic disorders, particularly that of diabetes, but also extend to certain types of cancer. CAS No. 42891-22-5. Molecular formula: C6H11NaO5S. Mole weight: 218.2. | |
| b-D-Thioglucose sodium salt hydrate | b-D-Thioglucose sodium salt hydrate, a biomedical compound, exerts significant influence in the realm of research. With its pivotal contribution to the comprehension of glucose metabolism and elucidation of diabetes pathogenesis, this compound emerges as an invaluable asset. Synonyms: 1-Thio-b-D-glucose sodium salt hydrate. CAS No. 255818-98-5. Molecular formula: C6H11NaO5S.H2O. Mole weight: 236.22. | |
| b-D-Xylopyranosyl azide | b-D-Xylopyranosyl azide, a remarkable biomedical product, stands as an indispensable tool in the intricate realm of carbohydrate chemistry. With its exceptional versatility and ready accessibility, this compound serves as a pivotal cornerstone for synthesizing a vast array of glycosides. Furthermore, its inherent potential transcends boundaries, empowering the creation of innovative drugs and targeted vaccines. Synonyms: beta-Xylopyranosyl azide; 51368-20-8; imino-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]iminoazanium. CAS No. 51368-20-8. Molecular formula: C5H9N3O4. Mole weight: 175.14. | |
| b-D-Xylopyranosyl nitromethane | b-D-Xylopyranosyl nitromethane, a biomedical product, finds wide application in the therapeutic management of diverse disorders. Exhibiting potential as a drug, it effectively combats microbial infections, cancer, and parasitic diseases. The distinctive chemical characteristics of b-D-Xylopyranosyl nitromethane demonstrate promising outcomes towards inhibiting tumor progression and curtailing pathogen proliferation. Synonyms: b-D-Xylopyranisylnitromethane. CAS No. 20204-84-6. Molecular formula: C6H11NO6. Mole weight: 193.2. | |
| BE-16627B | BE-16627B is a novel metalloproteinase (MP) inhibitor isolated from Streptomyces sp. BE16627B selectively inhibited MPs such as human stromelysin and 92 kD gelatinase. Synonyms: BE 16627B; BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)seryl-L-valine; N-[1, 3-Dihydroxy-2- ({1-hydroxy-2-[2-hydroxy-2- (hydroxyimino) ethyl]-4-methylpentylidene}amino) propylidene]valine. Grades: >98%. CAS No. 137530-61-1. Molecular formula: C31H35Cl2F6N3O3. Mole weight: 375.42. | |
| Becatecarin | Becatecarin is a synthetic diethylaminoethyl analogue of the indolocarbazole glycoside antineoplastic antibiotic rebeccamycin. Becatecarin intercalates into DNA and stabilizes the DNA-topoisomerase I complex, thereby interfering with the topoisomerase I-catalyzed DNA breakage-reunion reaction and initiating DNA cleavage and apoptosis. Synonyms: NSC 655649; BMS 181176; BMY 27557; 1,11-Dichloro-6-[2-(diethylamino)ethyl]-12,13-dihydro-12-(4-O-methyl-β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione; 5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione, 1,11-dichloro-6-[2-(diethylamino)ethyl]-12,13-dihydro-12-(4-O-methyl-β-D-glucopyranosyl)-. Grades: ≥95%. CAS No. 119673-08-4. Molecular formula: C33H34Cl2N4O7. Mole weight: 669.55. | |
| Bederocin | Bederocinis a MetS(methionyl-tRNA synthetase) inhibitor with antibacterial activity against clinical isolates of Staphylococcus aureus, Streptococcus pyogenes, and other clinically important gram-positive bacteria. But Bederocinis has little activity against gram-negative bacteria. Uses: Antibacterials. Synonyms: REP8839; REP-8839; REP 8839; 4(1H)-Quinolinone, 2-((3-(((4-bromo-5-(1-fluoroethenyl)-3-methyl-2-thienyl)methyl) mino)propyl)amino)-. Grades: 98%. CAS No. 757942-43-1. Molecular formula: C20H21BrFN3OS. Mole weight: 450.37. | |
| Befetupitant | Befetupitant is a potent and selective NK1 receptor antagonist. Befetupitant is potentially useful in controlling chemotherapy-induced nausea and vomiting. Synonyms: Ro 67-5930; Ro67-5930; Ro675930; Ro-675930; 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-morpholino-4-(o-tolyl)pyridin-3-yl)propanamide. Grades: >98%. CAS No. 290296-68-3. Molecular formula: C14H24Cl2N4O2. Mole weight: 565.56. | |
| Belantamab | Belantamab is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA). Belantamab can be used in the synthesis of Belantamab mafodotin, an ADC developed for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM). Synonyms: GSK2857914; GSK 2857914; GSK-2857914. CAS No. 2061894-48-0. | |
| Belotecan | Belotecan binds to and inhibits the activity of topoisomerase I, stabilizing the cleavable complex of topoisomerase I-DNA, which inhibits the religation of single-stranded DNA breaks generated by topoisomerase I. Uses: Topoisomerase i inhibitors. Synonyms: Camtobell; CKD602; CKD 602; CKD-602; (4S)-4-Ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione. CAS No. 256411-32-2. Molecular formula: C25H27N3O4. Mole weight: 433.50. | |
| Bemarituzumab | Bemarituzumab is a humanized monoclonal antibody that blocks FGFR2b. Bemarituzumab was approved for the treatment of tumors overexpressing FGFR2b. CAS No. 1952272-74-0. | |
| Benoxaprofen | Benoxaprofen is a non-steroidal anti-inflammatory drug. It was marketed by Eli Lilly and Company under the brand name Oraflex in the US and as Opren in Europe. Lilly suspended sales of Oraflex in 1982 after reports from the British government and the U.S. Food and Drug Administration of adverse effects and deaths linked to the drug. Synonyms: Coxigon; Inflamid; Opren; Oraflex. Grades: 98%. CAS No. 67434-14-4. Molecular formula: C16H12ClNO3. Mole weight: 301.72. | |
| Benzoic acid, 2,6-difluoro-4-[[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl]amino]- | Cas No. 191469-29-1. | |
| Benzoic acid-acyl-b-D-glucuronide | Benzoic acid-acyl-b-D-glucuronide is an integral metabolite and biomarker employed in biomedical research and pharmaceutical developments assuming a vital function in benzoic acid's metabolism and detoxification, thus facilitating the research of numerous ailments associated with its buildup. Synonyms: Benzoyl-acyl-b-D-glucuronide E210-acyl-b-D-glucuronide. CAS No. 19237-53-7. Molecular formula: C13H14O8. Mole weight: 298.25. | |
| Benzyl-2,3,3,6-tetra-O-acetyl-tio-D-glucopyranoside | | |
| Benzyl 2,3:4,6-di-O-benzylidene-a-D-mannopyranoside | Benzyl 2,3:4,6-di-O-benzylidene-a-D-mannopyranoside is a fascinating biomedicine marvel that holds tremendous potential in the realm of disease management. With its remarkable capability to inhibit the growth of cancer cells, particularly in the case of breast cancer, this compound emerges as a frontrunner in the quest for effective treatment options. Synonyms: Benzyl Dibenzylidene-alpha-D-mannopyranoside; Benzyl 2,3:4,6-di-O-benzylidene-a-D-mannopyranoside; (1R, 2S, 6S, 7S, 9R)-4, 12-Diphenyl-7-phenylmethoxy-3, 5, 8, 11, 13-pentaoxatricyclo[7.4.0.02, 6]tridecane; (3AS,4S,5aR,9aR,9bS)-4-(benzyloxy)-2,8-diphenylhexahydro-[1,3]dioxolo[4',5':4,5]pyrano[3,2-d][1,3]dioxine; Benzyl Dibenzylidene-a-D-mannopyranoside; Benzyl2,3:4,6-di-O-benzylidene-a-D-mannopyranoside; Benzyl Dibenzylidene-?-D-mannopyranoside; W-203203. CAS No. 58650-53-6. Molecular formula: C27H26O6. Mole weight: 446.49. | |
| Benzyl 2,3,4,6-tetra-O-acetyl-b-D-glucopyranoside | Benzyl 2,3,4,6-tetra-O-acetyl-b-D-glucopyranoside, an invaluable compound embraced by the biomedical industry, unveils its paramount significance. As a stalwart guardian in drug delivery, particularly across manifold ailments, it orchestrates marvels. Behold its transformative prowess: elevating drug stability, augmenting solubility, and expediting controlled release. CAS No. 10343-13-2. Molecular formula: C21H26O10. Mole weight: 438.43. | |
| Benzyl 2,3,4-tri-O-acetyl-4-nitromethyl-b-D-arabinopyranose | Benzyl 2,3,4-tri-O-acetyl-4-nitromethyl-b-D-arabinopyranose, an extensively researched chemical compound, exhibits immense promise in the realm of biomedical research. Its versatility extends to potential application in the development of drugs targeting a gamut of afflictions, spanning from cancer to infectious diseases. Synonyms: [(2R,3S,4S,5R)-4,5-diacetyloxy-5-(nitromethyl)-2-phenylmethoxyoxan-3-yl] acetate; Benzyl 2,3,4-Tri-O-acetyl-4-nitromethyl-beta-D-arabinopyranoside; Benzyl 2,3,4-Tri-O-acetyl-4-nitromethyl-?-D-arabinopyranoside; Benzyl 2,3,4-Tri-O-acetyl-4-nitromethyl- beta -D-arabinopyranoside; beta-D-Arabinopyranoside, phenylmethyl 4-C-(nitromethyl)-, 2,3,4-triacetate. CAS No. 383173-65-7. Molecular formula: C19H23NO10. Mole weight: 425.39. | |
| Benzyl 2,3:5,6-di-O-isopropylidene-a-D-mannofuranoside | Benzyl 2,3:5,6-di-O-isopropylidene-a-D-mannofuranoside is a valuable compound utilized in the biomedical industry. Known for its exceptional properties, this product finds application in the synthesis of novel drugs targeting specific diseases. Synonyms: (3aS,4S,6R,6aS)-6-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-4-phenylmethoxy-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole. CAS No. 20689-02-5. Molecular formula: C19H26O6. Mole weight: 350.41. | |
| Benzyl 2,3,6-Tri-O-benzyl-4-O-trifluoromethanesulfonyl-β-D-galactopyranoside | Benzyl 2,3,6-Tri-O-benzyl-4-O-trifluoromethanesulfonyl-β-D-galactopyranoside, a highly intricate and multifaceted chemical compound, assumes a paramount role in the realm of biomedicine. By virtue of its trifluoromethanesulfonyl moiety, it demonstrates unparalleled efficacy in repressing a diverse array of afflictions. Synonyms: Phenylmethyl 2,3,6-Tris-O-(phenylmethyl)-β-D-galactopyranoside Trifluoromethanesulfonate. CAS No. 182760-13-0. Molecular formula: C35H35F3O8S. Mole weight: 672.71. | |
| Benzyl-2,3-anhydro-a-D-ribopyranoside | Benzyl-2,3-anhydro-α-D-ribopyranoside is a key intermediate commonly used in the biomedical industry. It acts as a crucial building block for the synthesis of pharmaceuticals targeting various diseases, such as cancer, diabetes, and neurodegenerative disorders. This compound plays an essential role in drug development, aiding researchers in creating effective therapeutic treatments for these medical conditions. Synonyms: BENZYL-2,3-ANHYDRO-ALPHA-D-RIBOPYRANOSIDE; 61134-24-5. CAS No. 61134-24-5. Molecular formula: C12H14O4. Mole weight: 222.24. | |
| Benzyl 2,3-O-isopropylidene-6-O-trityl-5-keto-a-D-mannofuranose | Benzyl 2,3-O-isopropylidene-6-O-trityl-5-keto-a-D-mannofuranose is a versatile compound widely used in biomedicine. It acts as a key intermediate in the synthesis of various drugs targeting diseases such as cancer, diabetes, and viral infections. With its unique structural properties, this compound plays a crucial role in drug discovery and development. Synonyms: Benzyl 2,3-O-isopropylidene-a-D-lyxo-hexofuranosid-5-ulose. CAS No. 91364-12-4. Molecular formula: C35H34O6. Mole weight: 550.64. | |
| Benzyl 2,3-O-isopropylidene-6-O-trityl-5-keto-a-D-mannofuranoside 5-oxime | Benzyl 2,3-O-isopropylidene-6-O-trityl-5-keto-α-D-mannofuranoside 5-oxime, commonly employed in the research of precise disorders associated with mannose metabolism, showcases its relevant bioactivity. Synonyms: Benzyl 2,3-O-isopropylidene-6-O-trityl-a-D-lyxo-hexofuranoside-5-ulose oxime. CAS No. 91364-14-6. Molecular formula: C35H35NO6. Mole weight: 565.66. | |
| Benzyl 2,3-O-isopropylidene-6-O-trityl-a-D-mannofuranose | Benzyl 2,3-O-isopropylidene-6-O-trityl-a-D-mannofuranose is a crucial compound used in the synthesis of various drugs. It serves as a key intermediate in the development of pharmaceuticals targeting infectious diseases, including anti-viral and anti-bacterial agents. This compound plays a vital role in the biomedical industry for the research of specific drug-resistant strains and studying various infectious diseases. CAS No. 91364-11-3. Molecular formula: C35H36O6. Mole weight: 552.66. | |
| Benzyl 2,3-O-isopropylidene-a-D-mannofuranoside | Benzyl 2,3-O-isopropylidene-α-D-mannofuranoside, a widely employed compound in the biomedical sector, exhibits remarkable versatility. Its indispensability emerges from its role as a pivotal constituent in the synthesis of diverse pharmaceuticals and therapeutic interventions. Synonyms: alpha-D-Mannofuranoside, phenylmethyl 2,3-O-(1-methylethylidene)-; (1R)-1-[(3aS,4S,6R,6aS)-2,2-dimethyl-4-phenylmethoxy-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethane-1,2-diol; Benzyl 2,3-O-Isopropylidene-?-D-mannofuranoside. CAS No. 20689-03-6. Molecular formula: C16H22O6. Mole weight: 310.34. | |
| Benzyl 2,3-O-isopropylidene-L-glycero-a-D-mannoheptofuranoside | Benzyl 2,3-O-isopropylidene-L-glycero-a-D-mannoheptofuranoside is an intriguing compound, manifesting exceptional potential in studying diverse diseases. Through its remarkable inhibitory effects on select cellular enzymes, it acutely intervenes in crucial physiological processes. Synonyms: (1R,2S)-1-[(3aS,4S,6R,6aS)-2,2-dimethyl-4-phenylmethoxy-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propane-1,2,3-triol; Benzyl 2,3-O-Isopropylidene-L-glycero-alpha-D-mannoheptofuranoside; Benzyl 2,3-O-(1-methylethylidene)-beta-L-gulo-heptofuranoside; Benzyl 2,3-O-Isopropylidene-L-glycero-?-D-mannoheptofuranoside; Benzyl 2,3-O-isopropylidene-L-glycero-alpha-D-mannoheptofuranoside?. CAS No. 105592-29-8. Molecular formula: C17H24O7. Mole weight: 340.37. | |
| Benzyl 2-acetamido-2,4-dideoxy-4-fluoro-a-D-glucopyranose | Benzyl 2-acetamido-2,4-dideoxy-4-fluoro-α-D-glucopyranose, a remarkable compound, finds promising utility within the biomedical sphere for combatting bacterial infections. Its exceptional efficacy in impeding bacterial growth and thwarting disease causation has been substantiated. Synonyms: Phenylmethyl 2-(acetylamino)-2,4-dideoxy-4-fluoro-a-D-glucopyranoside. CAS No. 290819-73-7. Molecular formula: C15H20FNO5. Mole weight: 313.32. | |
| Benzyl-2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-a-D-glucopyranoside | Synonyms: Benzyl-2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-a-D-glucopyranoside; AKOS015919074; CS-0347633; Z1808050794; benzyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-alpha-d-glucopyranoside; (2r,3s,4r,5r,6s)-5-Acetamido-2-(acetoxymethyl)-6-(benzyloxy)tetrahydro-2h-pyran-3,4-diyl diacetate. Molecular formula: C21H27NO9. Mole weight: 437.4. | |
| Benzyl 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-D-glucopyranoside is an illustrious biochemical compound extensively employed in the biomedical sector assuming the role of a precursor for pharmaceutical intermediates and therapeutic drugs. This pivotal compound stands as a foundation for the research and development of antibiotics and antiviral compounds. Synonyms: Phenylmethyl 2-(acetylamino)-2-deoxy-b-D-glucopyranoside 3,4,6-triacetate. CAS No. 13343-66-3. Molecular formula: C21H27NO9. Mole weight: 437.44. | |
| Benzyl 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranoside | Benzyl 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranoside is a versatile compound widely used in the biomedical industry holding potential in studying various diseases, including bacterial and viral infections. This compound exhibits antibacterial and antiviral activities, making it suitable for the development of new drugs or as a research tool for studying the mechanisms of infection. Synonyms: Phenylmethyl 2-(Acetylamino)-2-deoxy-β-D-glucopyranoside 3,4,6-Triacetate. Grades: 98%. CAS No. 13341-66-3. Molecular formula: C21H27NO9. Mole weight: 437.44. | |
| Benzyl 2-Acetamido-2-deoxy-3,4-di-O-acetyl-α-D-glucopyranoside | A common intermediate used for the preparation of a variety of carbohydrates and oligosaccharides. Uses: A common intermediate used for the preparation of a variety of carbohydrates and oligosaccharides. Synonyms: Phenylmethyl 2-(Αcetylamino)-2-deoxy-α-D-glucopyranoside 3,4-Diacetate; Benzyl 2-Acetamido-2-deoxy-α-D-glucopyranoside 3,4-Diacetate. CAS No. 33401-01-3. Molecular formula: C19H25NO8. Mole weight: 395.4. | |
| Benzyl 2-acetamido-2-deoxy-3-O-methyl-a-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-3-O-methyl-a-D-glucopyranoside is an essential compound widely used in the biomedical industry utilized in the development of drugs and researchs for various diseases. With its unique structure, this compound serves as a crucial component in pharmaceutical research for targeting specific pathways and interactions related to compound delivery, glycosylation processes and cell signaling. CAS No. 93215-41-9. Molecular formula: C16H23NO6. Mole weight: 325.36. | |
| Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-b-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-b-D-glucopyranoside, a compound of immense significance in the realm of biomedicine, showcases extraordinary intricacy. With its role as a precursor in glycoconjugate synthesis to investigate drug-target interactions, this compound assumes a paramount position. Positioned at the forefront in combating bacterial and viral infections, cancer, and inflammatory disorders, it proves invaluable in evolving therapeutic approaches. Synonyms: BADIG. CAS No. 50605-12-4. Molecular formula: C18H25NO6. Mole weight: 351.39. | |
| Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-D-galactopyranoside | Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-D-galactopyranoside, a pivotal and indispensable compound prevalent in the biomedical domain, presents a profound significance. Integrating benzyl, acetamido, and galactopyranoside, this esteemed product finds wide application in the synthetic fabrication of glycosylated pharmaceuticals, serving as an invaluable tool for exploring lectin binding investigations. Furthermore, its versatile utilization encompasses investigating protein's sugar binding capacity and delving into the intricate interplay of carbohydrates in medicinal targeting and therapeutic strategies, thus highlighting its paramountcy in the field. CAS No. 75263-33-1. Molecular formula: C18H25NO6. Mole weight: 351.39. | |
| Benzyl 2-acetamido-2-deoxy-6-O-DMT-a-D-galactopyranoside | Benzyl 2-acetamido-2-deoxy-6-O-DMT-a-D-galactopyranoside is a biomedical compound exhibiting potential antimicrobial and anti-inflammatory activities, making it useful in the development of therapeutic drugs for infectious diseases. Molecular formula: C36H39NO8. Mole weight: 613.7. | |
| Benzyl 2-acetamido-2-deoxy-6-O-trityl-a-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-6-O-trityl-a-D-glucopyranoside, an extensively employed compound in the biomedical sector, showcases immense complexity and variability. As a cornerstone in glycoside synthesis for the advancement of pharmaceuticals and ailment interventions, this compound offers unparalleled potential. From crafting antiviral and antibacterial agents to revolutionary therapies in cancer and diabetes, its multipurpose attributes captivate the realms of biomedical exploration and innovation. Synonyms: N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-2-phenylmethoxy-6-(trityloxymethyl)oxan-3-yl]acetamide; BENZYL 2-ACETAMIDO-2-DEOXY-6-O-TRIPHENYL-METHYL-ALPHA-D-GLUCOPYRANOSIDE; N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-((trityloxy)methyl)tetrahydro-2H-pyran-3-yl)acetamide;BENZYL2-ACETAMIDO-2-DEOXY-6-O-TRIPHENYL-METHYL-ALPHA-D-GLUCOPYRANOSIDE; N-((2S,3R,4R,5S,6R)-2-(benzyloxy)-4,5-dihydroxy-6-(trityloxymethyl)tetrahydro-2H-pyran-3-yl)acetamide. CAS No. 33493-71-9. Molecular formula: C34H35NO6. Mole weight: 553.64. | |
| Benzyl 2-acetamido-2-deoxy-a-D-galactopyranoside | Benzyl 2-acetamido-2-deoxy-a-D-galactopyranoside, a versatile chemical compound extensively applied in the biomedical sector, manifests profound efficacy against targeted ailments encompassing bacterial infections and inflammation. Moreover, its potential as an enzymatic assay substrate and a primary component for synthesizing diverse pharmaceuticals is well-documented. Synonyms: Benzyl-alpha-galnac; 3554-93-6; Benzyl 2-acetamido-2-deoxy-alpha-D-galactopyranoside; Benzyl N-acetyl-alpha-D-galactosaminide; Benzyl-|A-GalNAc; Benzyl 2-acetamido-2-deoxy-a-D-galactopyranoside; N-[(2S,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-phenylmethoxyoxan-3-yl]acetamide; N-((2S,3R,4R,5R,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide; Bz-alpha-Galnac; Benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside; O-glycosylation-IN-1; benzyl-alpha-N-acetylgalactosamine; GalNAc-alpha-O-benzyl; MFCD00057920; GalNAc-O-bn; Benzyl-??-GalNAc; GalNAc alpha-O-benzyl; SCHEMBL542627; alpha-D-GalNAc-1-->OCH2Ph; DTXSID101293813; Phenylmethyl 2-(acetylamino)-2-deoxy-alpha-D-galactopyranoside; AKOS027382193; N-[(2S,3R,4R,5R,6R)-2-(benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide; MS-24534; HY-129389; CS-0105240; F87889; Benzyl 2-Acetamido-2-deoxy-?-D-galactopyranoside; W-202462; alpha-D-Galactopyranoside, phenylmethyl 2-(acetylamino)-2-deoxy-. CAS No. 3554-93-6. Molecular formula: C15H21NO6. Mole weight: 311.33. | |
| Benzyl 2-acetamido-2-deoxy-a-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-a-D-glucopyranoside is an intriguing biochemical compound, exhibiting profound efficacy in studying diverse infections triggered by pernicious bacteria and virulent viruses. Synonyms: Benzyl D-GlcNAc. CAS No. 13343-62-9. Molecular formula: C15H21NO6. Mole weight: 311.33. | |
| Benzyl 2-acetamido-2-deoxy-b-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-b-D-glucopyranoside is a biomedical compound used for studying bacterial infections by inhibiting biofilm formation. Furthermore, it shows potential in cancer research as a novel glycosylation inhibitor, offering promising avenues for drug discovery and development. Synonyms: Benzyl 2-Acetamido-2-deoxy-beta-D-glucopyranoside; Benzyl 2-acetamido-2-deoxy-b-D-glucopyranoside; CHEMBL1818656; N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-phenylmethoxyoxan-3-yl]acetamide; N-((2R,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide; SCHEMBL542635; DTXSID201236521; BDBM50466400; MFCD00070372; AKOS015910500; Benzyl 2-Acetamido-2-deoxy-?-D-glucopyranoside; Benzyl 2-Acetamido-2-deoxy- beta -D-glucopyranoside; b-D-Glucopyranoside,phenylmethyl2-(acetylamino)-2-deoxy-; Phenylmethyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside; N-[(2R,3R,4R,5S,6R)-2-(BENZYLOXY)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-3-YL]ACETAMIDE. CAS No. 13343-67-4. Molecular formula: C15H21NO6. Mole weight: 311.33. | |
| Benzyl 2-acetamido-2-deoxy-D-glucopyranoside | Benzyl 2-acetamido-2-deoxy-D-glucopyranoside is a synthetic compound widely used in the biomedical industry acting as an efficient substrate for enzymes to catalyze specific reactions. Its applications include the development of pharmaceutical drugs targeting bacterial infections and diseases related to abnormal glycosylation. It is utilized in biochemical research and drug discovery processes to investigate cellular functions and molecular mechanisms. Synonyms: Benzyl D-GlcNAc. CAS No. 3055-51-4. Molecular formula: C15H21NO6. Mole weight: 311.33. | |
| Benzyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranoside | Benzyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranoside is a multifaceted biomedical compound, showcasing potential in research of diverse carbohydrate metabolism disorders. CAS No. 141019-71-8. Molecular formula: C21H27NO9. Mole weight: 437.44. | |
| Benzyl 2-acetamido-3,4-di-O-acetyl-2-deoxy-6-O-DMT-a-D-galactopyranoside | Benzyl 2-acetamido-3,4-di-O-acetyl-2-deoxy-6-O-DMT-a-D-galactopyranoside is a biomolecular with applications encompassing the domains of targeted receptor-oriented drug delivery and in-depth exploration of cellular intricacies. Its profound impact extends to research of bacterial infections, grappling with malignant tumours and studying various inflammatory maladies. Molecular formula: C40H43NO10. Mole weight: 697.77. | |
Our database is helping our users find suppliers everyday.
